Barrett’s esophagus is a condition in which chronic acid reflux causes the normal lining of the lower esophagus to be replaced by tissue more similar to the intestinal lining. This cellular change, known as intestinal metaplasia, increases the risk of developing esophageal adenocarcinoma — one of the fastest-rising cancers in the United States. Understanding who is at risk, why surveillance matters, and what treatment options exist is critical for patients with longstanding GERD.
What Is Barrett’s Esophagus?
Barrett’s esophagus is a complication of chronic gastroesophageal reflux disease in which repeated acid exposure causes the squamous cell lining of the lower esophagus to transform into specialized columnar epithelium resembling intestinal tissue. This change is called intestinal metaplasia and is confirmed by endoscopic biopsy. While Barrett’s esophagus itself is not cancer, it represents a precancerous condition that requires ongoing surveillance.
What Causes This Condition?
The primary cause of Barrett’s esophagus is longstanding GERD. Chronic acid and bile exposure to the esophageal lining triggers cellular changes as the body attempts to protect itself from ongoing injury. Not everyone with GERD develops Barrett’s esophagus, and the exact factors that determine who will undergo this transformation are not fully understood. Genetics, obesity, male sex, and smoking are known risk factors.
Risk Factors for Barrett’s Esophagus
Barrett’s esophagus is most commonly found in middle-aged and older men with a history of chronic GERD. Risk factors include obesity, particularly central abdominal fat, which increases intra-abdominal pressure and promotes acid reflux. Smoking, a family history of Barrett’s esophagus or esophageal cancer, and white race also contribute to elevated risk. Women and people of other ethnicities are less commonly affected but not immune.
Symptoms of Barrett’s Esophagus
Barrett’s esophagus does not cause specific symptoms beyond those of underlying GERD, such as heartburn, regurgitation, and difficulty swallowing. Some patients are surprised to receive a Barrett’s diagnosis because their reflux symptoms were mild or well-controlled. The absence of prominent symptoms does not reduce the importance of surveillance, as the cellular changes that lead to cancer occur at the tissue level independent of symptom severity.
How Barrett’s Esophagus Is Diagnosed
Diagnosis requires upper endoscopy with biopsy. During the procedure, the gastroenterologist identifies the characteristic salmon-colored lining in the lower esophagus and takes multiple tissue samples for pathological analysis. A Barrett’s diagnosis is confirmed when the pathologist identifies the presence of goblet cells in the esophageal lining. Endoscopy is the only way to diagnose this condition and assess its extent.
Dysplasia: The Critical Next Step
Once Barrett’s esophagus is diagnosed, surveillance focuses on detecting dysplasia — abnormal cellular changes that precede cancer. Dysplasia is graded as low-grade or high-grade based on the degree of cellular abnormality. High-grade dysplasia indicates cells on the verge of becoming cancerous and requires treatment. Low-grade dysplasia requires more frequent surveillance and may also benefit from early intervention in appropriate patients.
Cancer Risk With Barrett’s Esophagus
Patients with Barrett’s esophagus face an elevated risk of developing esophageal adenocarcinoma compared to the general population, though the absolute annual risk remains relatively low at approximately 0.3 percent per year. The risk is significantly higher in patients with confirmed dysplasia, particularly high-grade dysplasia. This is why surveillance endoscopy is essential — detecting dysplasia early allows for intervention before invasive cancer develops.
Surveillance Endoscopy Guidelines
Surveillance intervals for Barrett’s esophagus depend on whether dysplasia is present and its grade. Non-dysplastic Barrett’s typically requires surveillance endoscopy every three to five years. Low-grade dysplasia warrants follow-up in six months to a year. High-grade dysplasia or early cancer requires immediate intervention. Adhering to the recommended surveillance schedule is the most important thing a patient with Barrett’s can do to protect against cancer.
Endoscopic Treatment for Barrett’s Esophagus
Several endoscopic therapies are available for treating Barrett’s esophagus with dysplasia. Radiofrequency ablation uses controlled heat energy delivered via endoscopy to eliminate the abnormal tissue while sparing the underlying esophageal wall. Cryotherapy uses cold energy. Endoscopic mucosal resection removes raised lesions for both treatment and detailed pathological staging. These procedures achieve high rates of complete eradication of dysplastic tissue.
Radiofrequency Ablation in Detail
Radiofrequency ablation, or RFA, is the most commonly used and best-studied endoscopic treatment for Barrett’s esophagus with dysplasia. The procedure uses a catheter with a balloon or probe that delivers precise thermal energy to ablate the abnormal esophageal lining. Normal squamous cells regenerate to replace the treated tissue. Multiple sessions may be needed, and surveillance continues after eradication to detect recurrence.
Surgical Options for Advanced Barrett’s
For patients with invasive esophageal cancer arising from Barrett’s esophagus, esophagectomy — surgical removal of part or all of the esophagus — may be required. However, the goal of endoscopic surveillance and treatment is precisely to prevent progression to this point. When Barrett’s is identified early and treated before invasive cancer develops, patients can often avoid major surgery entirely.
GERD Management and Barrett’s Esophagus
Optimizing GERD control is an important component of managing Barrett’s esophagus. While acid suppression with proton pump inhibitors does not reliably reverse Barrett’s changes or eliminate cancer risk, it reduces ongoing acid injury to the esophageal lining. Some evidence suggests long-term PPI therapy may slow progression. Surgical antireflux procedures may be considered for patients with poorly controlled GERD.
Lifestyle Changes That Help
The same lifestyle modifications that reduce GERD symptoms also benefit patients with Barrett’s esophagus. Maintaining a healthy weight, elevating the head of the bed, avoiding meals close to bedtime, eliminating smoking, limiting alcohol, and reducing fatty and acidic foods all minimize ongoing acid exposure to the esophageal lining. These changes complement medical and endoscopic management but do not replace surveillance.
The Role of the Gastroenterologist
Barrett’s esophagus requires lifelong management by a gastroenterologist with expertise in esophageal disease and advanced endoscopic procedures. This includes performing high-quality surveillance endoscopy, interpreting dysplasia grades accurately, selecting and performing appropriate ablative therapies, and optimizing GERD management. Patients with Barrett’s esophagus deserve specialist care that follows evidence-based guidelines.
Why Vigilance Makes All the Difference
Barrett’s esophagus is a manageable condition when patients remain engaged in their surveillance schedule and work closely with a gastroenterologist. The progression from Barrett’s to dysplasia to cancer is a process that takes years and can be interrupted at multiple points with appropriate intervention. Patients who maintain regular endoscopic surveillance and pursue treatment when dysplasia is found dramatically reduce their cancer risk.
Call To Action
If you are experiencing digestive symptoms or are due for preventive screening, professional gastroenterology care can make a meaningful difference. Learn more about available services or schedule an appointment by visiting Gastro Florida.
Citations
NIH – Barrett’s Esophagus
https://www.niddk.nih.gov/health-information/digestive-diseases/barretts-esophagus
Mayo Clinic – Barrett’s Esophagus
https://www.mayoclinic.org/diseases-conditions/barretts-esophagus
Cleveland Clinic – Barrett’s Esophagus Treatment
https://my.clevelandclinic.org/health/diseases/6041-barretts-esophagus
For education only, not medical advice.
Close